PDSB

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

PDS Biotechnology Corp

NASDAQ | PDSB

0.73

USD

$0.00

(

0.00%

)

At Close (As of Dec 1, 2025)

$42.19M

Market Cap

-

P/E Ratio

-0.81

EPS

$2.46

52 Week High

$0.72

52 Week Low

HEALTHCARE

Sector

PDSB Chart

Recent Chart
Price Action

PDSB Technicals

Tags:

PDSB Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$60K
Total Revenue $0
Cost Of Revenue $60K
Costof Goods And Services Sold $60K
Operating Income -$36M
Selling General And Administrative $13M
Research And Development $23M
Operating Expenses $36M
Investment Income Net -
Net Interest Income -$2.2M
Interest Income $2.5M
Interest Expense $4.7M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $60K
Income Before Tax -$38M
Income Tax Expense -$869K
Interest And Debt Expense -
Net Income From Continuing Operations -$38M
Comprehensive Income Net Of Tax -
Ebit -$34M
Ebitda -$34M
Net Income -$38M

Revenue & Profitability

Earnings Performance

PDSB Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $45M
Total Current Assets $45M
Cash And Cash Equivalents At Carrying Value $42M
Cash And Short Term Investments $42M
Inventory -
Current Net Receivables -
Total Non Current Assets $304K
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments -
Other Current Assets $3.4M
Other Non Current Assets -
Total Liabilities $26M
Total Current Liabilities $17M
Current Accounts Payable $1.7M
Deferred Revenue -
Current Debt -
Short Term Debt $13M
Total Non Current Liabilities $9.3M
Capital Lease Obligations $123K
Long Term Debt $9.2M
Current Long Term Debt $13M
Long Term Debt Noncurrent -
Short Long Term Debt Total $22M
Other Current Liabilities $2.8M
Other Non Current Liabilities -
Total Shareholder Equity $19M
Treasury Stock -
Retained Earnings -$182M
Common Stock $13K
Common Stock Shares Outstanding $36M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$35M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $21K
Capital Expenditures $29K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$29K
Cashflow From Financing $20M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$38M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$60K
Total Revenue $0
Cost Of Revenue $60K
Costof Goods And Services Sold $60K
Operating Income -$36M
Selling General And Administrative $13M
Research And Development $23M
Operating Expenses $36M
Investment Income Net -
Net Interest Income -$2.2M
Interest Income $2.5M
Interest Expense $4.7M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $60K
Income Before Tax -$38M
Income Tax Expense -$869K
Interest And Debt Expense -
Net Income From Continuing Operations -$38M
Comprehensive Income Net Of Tax -
Ebit -$34M
Ebitda -$34M
Net Income -$38M

PDSB News

PDSB Profile

PDS Biotechnology Corp Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

PDS Biotechnology Corporation (PDSB), based in Florham Park, New Jersey, is a clinical-stage biopharmaceutical firm dedicated to advancing cancer immunotherapies via its proprietary Versamune® platform. The company is actively developing multifunctional therapies aimed at bolstering the immune response against cancers, with its lead candidate, PDS0101, currently in clinical trials targeting HPV-related malignancies. By focusing on innovative solutions that address significant unmet needs in oncology, PDSB is well-positioned to make substantial contributions to the biopharmaceutical landscape and potentially transform cancer treatment paradigms.

LPTX
+368.57%
$2.05
DRCT
+15.27%
$0.13
QTTB
+99.54%
$4.37
PAVS
-90.66%
$0.09
HBI
-1.82%
$6.47
VINE
+21.21%
$0.48
NVDA
+1.59%
$179.83
IPG
-1.95%
$24.57
TWOH
-15.38%
$0.00
AXDX
-61.36%
$0.03
IVP
+2.98%
$0.12
FTEL
+53.00%
$1.30
ADAP
-15.14%
$0.05
BITF
-6.04%
$3.26
CHR
+4.09%
$0.04
SOND
-23.45%
$0.12
RMBL
+60.50%
$3.21
ASST
-8.92%
$1.02
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
BURU
-4.91%
$0.23
INTC
-1.59%
$39.91
NFE
+18.70%
$1.44
SRM
+53.27%
$10.30
BMNR
-11.98%
$29.15
CNEY
-15.45%
$1.23
AHMA
+148.64%
$11.96
NIO
-5.90%
$5.17
RPGL
+9.35%
$0.44
WULF
+4.51%
$15.51
TLRY
-3.72%
$0.78
WLGS
-5.57%
$0.04
CLSK
-4.07%
$14.48
BYND
+2.87%
$1.01
MTSR
-0.35%
$70.50
TSLA
-0.70%
$427.12
BMNU
-24.25%
$6.20
PLUG
-4.44%
$1.92
ONDS
-3.35%
$7.63
SNAP
-0.60%
$7.63
MARA
-6.26%
$11.07
YGMZ
+3.32%
$0.11
AFMD
-34.94%
$0.18
AAL
-0.08%
$14.03
SOFI
-0.89%
$29.45
F
+0.11%
$13.29
INHD
-16.81%
$0.18
AMZN
+1.77%
$233.22
NWTN
-9.09%
$0.70
AG
+12.73%
$15.23
GRYP
-10.38%
$1.38
PRPH
-19.10%
$0.16
CAN
-6.65%
$0.94
PFE
-1.18%
$25.43
MODV
-25.22%
$0.43
MSTR
-10.66%
$158.28
NCT
-36.96%
$0.48
BTG
-0.54%
$4.59
PLTR
+1.61%
$168.45
RIVN
+2.72%
$17.32
CIFR
-5.28%
$19.27
DNN
+0.03%
$2.56
T
+0.77%
$26.02
HOOD
-5.73%
$121.12
VHAI
-25.00%
$0.00
GOOGL
-0.82%
$317.54
RUBI
-11.15%
$0.14
RIG
+0.22%
$4.42
SAND
-6.04%
$12.12
SHOT
-74.37%
$0.39
AMD
-0.08%
$217.35
ZAPP
-46.30%
$0.15
DVLT
-4.17%
$1.94
BBD
-1.21%
$3.65
CPNG
-4.79%
$26.81
WBUY
+39.26%
$2.20
GRAB
-2.44%
$5.31
PLTD
+0.21%
$7.05
GPUS
-7.57%
$0.27
IBRX
0.00%
$2.36
ACHR
-4.89%
$7.40
RGTI
-6.39%
$23.93
HBAN
+1.47%
$16.54
HL
+2.43%
$17.23
BBWI
+8.87%
$18.95
GOOG
-0.65%
$318.01
DEFT
-10.69%
$1.35
BAC
+0.00%
$53.65
ITUB
-1.15%
$7.71
IREN
-4.12%
$45.84
BTBT
-8.54%
$2.17
APLD
+3.12%
$27.94
EXK
-4.48%
$9.48
BTE
-0.15%
$3.21
TE
+8.61%
$4.47
SKYQ
-1.45%
$0.34
AAPL
-0.36%
$277.84
SOUN
-0.62%
$11.97
CRCL
-4.05%
$76.69
AMZE
+4.79%
$0.50
LPTX
+368.57%
$2.05
DRCT
+15.27%
$0.13
QTTB
+99.54%
$4.37
PAVS
-90.66%
$0.09
HBI
-1.82%
$6.47
VINE
+21.21%
$0.48
NVDA
+1.59%
$179.83
IPG
-1.95%
$24.57
TWOH
-15.38%
$0.00
AXDX
-61.36%
$0.03
IVP
+2.98%
$0.12
FTEL
+53.00%
$1.30
ADAP
-15.14%
$0.05
BITF
-6.04%
$3.26
CHR
+4.09%
$0.04
SOND
-23.45%
$0.12
RMBL
+60.50%
$3.21
ASST
-8.92%
$1.02
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
BURU
-4.91%
$0.23
INTC
-1.59%
$39.91
NFE
+18.70%
$1.44
SRM
+53.27%
$10.30
BMNR
-11.98%
$29.15
CNEY
-15.45%
$1.23
AHMA
+148.64%
$11.96
NIO
-5.90%
$5.17
RPGL
+9.35%
$0.44
WULF
+4.51%
$15.51
TLRY
-3.72%
$0.78
WLGS
-5.57%
$0.04
CLSK
-4.07%
$14.48
BYND
+2.87%
$1.01
MTSR
-0.35%
$70.50
TSLA
-0.70%
$427.12
BMNU
-24.25%
$6.20
PLUG
-4.44%
$1.92
ONDS
-3.35%
$7.63
SNAP
-0.60%
$7.63
MARA
-6.26%
$11.07
YGMZ
+3.32%
$0.11
AFMD
-34.94%
$0.18
AAL
-0.08%
$14.03
SOFI
-0.89%
$29.45
F
+0.11%
$13.29
INHD
-16.81%
$0.18
AMZN
+1.77%
$233.22
NWTN
-9.09%
$0.70
AG
+12.73%
$15.23
GRYP
-10.38%
$1.38
PRPH
-19.10%
$0.16
CAN
-6.65%
$0.94
PFE
-1.18%
$25.43
MODV
-25.22%
$0.43
MSTR
-10.66%
$158.28
NCT
-36.96%
$0.48
BTG
-0.54%
$4.59
PLTR
+1.61%
$168.45
RIVN
+2.72%
$17.32
CIFR
-5.28%
$19.27
DNN
+0.03%
$2.56
T
+0.77%
$26.02
HOOD
-5.73%
$121.12
VHAI
-25.00%
$0.00
GOOGL
-0.82%
$317.54
RUBI
-11.15%
$0.14
RIG
+0.22%
$4.42
SAND
-6.04%
$12.12
SHOT
-74.37%
$0.39
AMD
-0.08%
$217.35
ZAPP
-46.30%
$0.15
DVLT
-4.17%
$1.94
BBD
-1.21%
$3.65
CPNG
-4.79%
$26.81
WBUY
+39.26%
$2.20
GRAB
-2.44%
$5.31
PLTD
+0.21%
$7.05
GPUS
-7.57%
$0.27
IBRX
0.00%
$2.36
ACHR
-4.89%
$7.40
RGTI
-6.39%
$23.93
HBAN
+1.47%
$16.54
HL
+2.43%
$17.23
BBWI
+8.87%
$18.95
GOOG
-0.65%
$318.01
DEFT
-10.69%
$1.35
BAC
+0.00%
$53.65
ITUB
-1.15%
$7.71
IREN
-4.12%
$45.84
BTBT
-8.54%
$2.17
APLD
+3.12%
$27.94
EXK
-4.48%
$9.48
BTE
-0.15%
$3.21
TE
+8.61%
$4.47
SKYQ
-1.45%
$0.34
AAPL
-0.36%
$277.84
SOUN
-0.62%
$11.97
CRCL
-4.05%
$76.69
AMZE
+4.79%
$0.50
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.